跳至主要内容
临床试验/NCT01374347
NCT01374347已完成不适用

Brain SPECT Perfusion Imaging Following Cialis (Tadalafil ) Administration in Patients With Vascular Risk Factors

Wolfson Medical Center0 个研究点目标入组 30 人开始时间: 2011年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30

研究概览

简要总结

The study will be an open label one and will include 30 patients who underwent ischemic stroke 3 month to 3 years prior to the study. All patients will undergone a baseline brain SPECT perfusion study. 15 patients will take one dose of 20 mg cialis, and will have a second brain SPECT 24 hours after cialis administration. 15 other patients (age and risk factor matched) will be prescribed 5 mg of cialis once daily for 7 days, and a second SPECT study will be performed 24 hours after the last dose.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
35 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male and female patients in the age range of 35-75 years.

排除标准

  • known allergic reaction to TF
  • Medical contraindication to use TF
  • Hemorrhagic stroke including intracerebral hemorrhage and subarachnoid hemorrhage
  • Acute stroke or cardiac ischemic event up to 3 month prior to study.
  • Other neurological brain diseases including degenerative diseases, multiple sclerosis, brain tumors, post severe brain injury (TBI) and migraine headache.
  • Sensory aphasia.
  • Cognitive impairment with disability to sign a consent form.Patients' Assessment

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Mordechai Lorberboym Prof

PI

Wolfson Medical Center

相似试验